At AirICU, we are firm believers that competition sparks innovation, while monopoly breeds stagnation. It is the challenge from competitors that pushes us to think differently, work harder, and deliver better solutions.Our journey reflects this principle. For years, the nebulization market was shaped by a single technology that, protected by patents, left little room for […]
We have recently become aware that a competitor has initiated a malicious and unfounded trademark lawsuit against our AirICU brand, without any legitimate basis or supporting evidence. This legal action appears to be a deliberate attempt to disrupt fair market competition, and is accompanied by efforts to intimidate and harass our customers, urging them to […]
IntroductionStatus asthmaticus is a life-threatening condition and one of the leading causes of admission to pediatric intensive care units (PICU). While asthma prevalence has plateaued and hospital admissions for asthma have declined, the incidence of ICU-level care for children with status asthmaticus continues to rise. Inhaled albuterol administered via continuous nebulization is the most commonly […]
AbstractMechanically ventilated patients with acute respiratory distress syndrome (ARDS) often receive aerosolized iloprost. Due to the short half-life of prostacyclin, extending the duration of inhalation could enhance its clinical effectiveness, though this presents technical difficulties. One potential solution is the use of inspiration-synchronized vibrating mesh nebulizers (VMNsyn), which offer high drug deposition rates and prolonged […]
Background: A breath-synchronized nebulization option that could potentially improve drug delivery during noninvasive positive pressure ventilation (NIPPV) is currently not available on single-limb circuit bilevel ventilators. The aim of this study was to compare urinary excretion of amikacin following aerosol delivery with a vibrating mesh nebulizer coupled to a single-limb circuit bilevel ventilator, using conventional […]
Introduction Chronic obstructive pulmonary disease (COPD) is a progressive lung condition resulting from damage caused by harmful chemicals. These chemicals trigger a series of inflammatory responses that not only harm lung structure but also increase mucus production in the airways. COPD is characterized as a partially reversible condition with restricted airflow, leading to permanent damage […]
中国大陆
简体中文
United Kingdom
English
